Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Peckham

Showing results (81-90 of 88) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 88 results.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 25, 2016
Diagnostic and prognostic significance of systemic alkyl quinolones for P. aeruginosa in cystic fibrosis: A longitudinal studyHelen L Barr, Nigel Halliday, David A Barrett, et al.
Plos One|December 28, 2020
Oral cysteamine as an adjunct treatment in cystic fibrosis pulmonary exacerbations: An exploratory randomized clinical trialGraham Devereux, Danielle Wrolstad, Stephen J Bourke, et al.
The European Respiratory Journal|April 2, 2021
Higher throughput drug screening for rare respiratory diseases: readthrough therapy in primary ciliary dyskinesiaDani Do Hyang Lee, Daniela Cardinale, Ersilia Nigro, et al.
Hepatology (Baltimore, Md.)|November 7, 2023
Cystic fibrosis screening, evaluation, and management of hepatobiliary disease consensus recommendationsZachary M Sellers, David N Assis, Shruti M Paranjape, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 2, 2026
Effects of Elexacaftor/Tezacaftor/Ivacaftor on cough frequency, physical activity patterns, and sleep quality in adolescents and adults with cystic fibrosisEva Van Braeckel, Andrew T Braun, Nicholas J Simmonds, et al.
The New England Journal of Medicine|August 12, 2011
Intrapleural use of tissue plasminogen activator and DNase in pleural infectionNajib M Rahman, Nicholas A Maskell, Alex West, et al.
ERJ Open Research|August 19, 2022
The disease-specific clinical trial network for primary ciliary dyskinesia: PCD-CTNJohanna Raidt, Bernard Maitre, Petra Pennekamp, et al.
Science (New York, N.Y.)|November 16, 2016
Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacteriumJosephine M Bryant, Dorothy M Grogono, Daniela Rodriguez-Rincon, et al.
Pageof 9

Showing results (81-90 of 88) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 25, 2016
Diagnostic and prognostic significance of systemic alkyl quinolones for P. aeruginosa in cystic fibrosis: A longitudinal studyHelen L Barr, Nigel Halliday, David A Barrett, et al.
Plos One|December 28, 2020
Oral cysteamine as an adjunct treatment in cystic fibrosis pulmonary exacerbations: An exploratory randomized clinical trialGraham Devereux, Danielle Wrolstad, Stephen J Bourke, et al.
The European Respiratory Journal|April 2, 2021
Higher throughput drug screening for rare respiratory diseases: readthrough therapy in primary ciliary dyskinesiaDani Do Hyang Lee, Daniela Cardinale, Ersilia Nigro, et al.
Hepatology (Baltimore, Md.)|November 7, 2023
Cystic fibrosis screening, evaluation, and management of hepatobiliary disease consensus recommendationsZachary M Sellers, David N Assis, Shruti M Paranjape, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 2, 2026
Effects of Elexacaftor/Tezacaftor/Ivacaftor on cough frequency, physical activity patterns, and sleep quality in adolescents and adults with cystic fibrosisEva Van Braeckel, Andrew T Braun, Nicholas J Simmonds, et al.
The New England Journal of Medicine|August 12, 2011
Intrapleural use of tissue plasminogen activator and DNase in pleural infectionNajib M Rahman, Nicholas A Maskell, Alex West, et al.
ERJ Open Research|August 19, 2022
The disease-specific clinical trial network for primary ciliary dyskinesia: PCD-CTNJohanna Raidt, Bernard Maitre, Petra Pennekamp, et al.
Science (New York, N.Y.)|November 16, 2016
Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacteriumJosephine M Bryant, Dorothy M Grogono, Daniela Rodriguez-Rincon, et al.
Pageof 9